SBI Life Q4 FY25 Results: APE jumps 9% to Rs 21,420 crore, VoNB Margin stands at 27.8%

SBI Life Insurance has reported a solid performance for the financial year ended March 31, 2025, with the company showcasing resilience and profitability across key growth indicators. The Annualized Premium Equivalent (APE) grew 9% year-on-year to ₹214.2 billion, up from ₹197.2 billion in FY24, reflecting stronger momentum in its retail premium segments. The company’s Value of New Business (VoNB) rose 7% to ₹59.5 billion for FY25, compared to ₹55.5 billion in the previous year.

Despite a slight dip from 28.1% in FY24, SBI Life maintained a healthy VoNB margin of 27.8% this year, continuing to demonstrate robust profitability from its new business operations. Notably, individual new business sum assured also surged 43% to ₹2,769 billion, signaling aggressive growth in coverage expansion.

Advertisement

Key Highlights:

  • APE: ₹214.2 billion (+9% YoY)

  • VoNB: ₹59.5 billion (+7% YoY)

  • VoNB Margin: 27.8%

  • PAT: ₹24.1 billion (+27% YoY)

  • IEV: ₹702.5 billion (+21% YoY)

  • AuM: ₹4.48 trillion (+15% YoY)

  • 13th Month Persistency: 87.4%

  • 61st Month Persistency: 62.7%

  • Solvency Ratio: 1.96

  • RoE: 15.1%

Additionally, SBI Life reported a 27% growth in profit after tax (PAT), which stood at ₹24.1 billion for the year, while its Indian Embedded Value (IEV) grew by 21% year-on-year to ₹702.5 billion. The company’s solvency ratio remained strong at 1.96, well above regulatory requirements.

Amit Jhingran, MD & CEO of SBI Life stated: FY25 was an exceptional year on every front. Standing at the intersection of regulatory changes, evolving customer needs and digital acceleration, we responded with resilience and conviction. Our team exhibited exceptional agility in adapting to customer needs, innovated boldly to reshape experiences and scaled efficiently to make the benefit of life insurance available to every Indian. I am delighted to share that with a 12% growth in Individual Rated Premium, SBI Life outperformed industry growth of 10.5%. This speaks volumes about the strength and dedication of our teamwork, the trust that customers place in us and the excellence with which we execute our strategy.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.